Delaware Court Overturns $50 Million Patent Verdict Against Amgen Amid Misconduct Claims
In a significant legal development, a Delaware federal judge overturned a $50 million patent infringement verdict against Amgen, a well-known name in the biotechnology sector. The decision arose after it was revealed that crucial information was intentionally withheld during the patent application process. This action was linked to an inventor associated with the German biotech…